- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
3347
HKG
Week ended 07 Aug 2026
Weekly Investor Report
Hangzhou Tigermed Consulting Co., Ltd · Healthcare · Diagnostics & Research
Latest close
41.22 HKD
9.3%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 0.9% above the Trend Line and sits at 38.5% of its 52-week range. The latest completed week returned 9.3%, after a 12.4% four-week move. The latest news-sentiment score is 54/100.
Setup score
42
out of 100
Latest Close
41.22 HKD
7 Aug 2026
1W Return
9.3%
latest completed week
4W Return
12.4%
short-term follow-through
12W Return
15.7%
quarterly tape
Trend Breadth
28.8%
15 of 52 weeks active
Volume Ratio
1.2x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Next-week expectancy is negative at 42.97% based on similar historical setup states.
- Activity pressure is weak, so confirmation is not yet broad enough.
- The share remains more than 20% below its 52-week high.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
9.3%
Latest completed week; four-week move 12.4%.
Indicator stack
16/74
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 42.97%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
54/100
4 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 0.9% above the Trend Line and sits at 38.5% of its 52-week range. The latest completed week returned 9.3%, after a 12.4% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.2x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0912-week average 0.04
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure3/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.09Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 12.4% over four weeks, 15.7% over 12 weeks, and -21.7% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year15
Trend breadth28.8%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.55Latest activity-pressure read.
Pressure change178.4%Four-week change in activity pressure.
Leadership-2.75Latest relative-leadership reading.
RS change74.2%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment54/100
Weighted news tone is neutral across 4 relevant articles.
1 positive · 3 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-31.2%Distance below the 52-week high.
13-week volatility5.4%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher12 of 2614 weeks finished lower.
Best week+9.3%Week of 7 Aug.
Worst week-10.5%Week of 22 May.
Latest week+9.3%Week of 7 Aug.
Shape of recent returns
Strong gains4
Modest gains8
Flat weeks0
Modest losses7
Sharp losses7
Recent vol5.4%13-week weekly-return volatility.
Base vol6.9%52-week weekly-return volatility.
Up/down split25/27Count of positive and negative weeks in the 52-week window.
Average skew5.4% / -5.5%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorHK Healthcare
4-week rank13 / 100
Group average4.4%
Trend breadth12.0%
Trend12.0%active weekly trend signals
MD32.0%positive activity pressure
RS19.0%positive relative leadership
Four-week leaders
IndustryHK Diagnostics & Research
4-week rank5 / 13
Group average12.4%
Trend breadth7.7%
Trend7.7%active weekly trend signals
MD61.5%positive activity pressure
RS46.2%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape35/100
Trend, activity pressure, participation, and risk combine to a 35/100 tape read.
Indicator analysis15/100Latest 12-week confirmation: trend 0/12, activity pressure 3/12, relative leadership 0/12.
Activity pressure 0.09; No reversal markers Next-Week ExpectancyNegative 42.97%Next-week expectancy is negative with a 42.97% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment54/100Weighted news tone is neutral across 4 relevant articles.
Hangzhou Tigermed Directors Investigated by CSRC for Suspected Information Disclosure Violations Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 41.22 HKD | 9.3% | 40.87 HKD | 36.80 HKD | 0.55 | -2.75 | 8.9M | Off |
| 31 Jul 2026 | 37.72 HKD | 1.4% | 41.20 HKD | 36.82 HKD | 0.33 | -12.27 | 5.3M | Off |
| 24 Jul 2026 | 37.20 HKD | 1.4% | 41.35 HKD | 36.89 HKD | 0.04 | -11.05 | 9.5M | Off |
| 17 Jul 2026 | 36.70 HKD | 0.1% | 41.51 HKD | 36.96 HKD | -0.31 | -11.40 | 14.6M | Off |
| 10 Jul 2026 | 36.66 HKD | 2.5% | 41.67 HKD | 37.01 HKD | -0.70 | -10.66 | 11.6M | Off |
| 3 Jul 2026 | 35.76 HKD | 5.2% | 41.77 HKD | 37.07 HKD | -1.06 | -10.34 | 1.3M | Off |
| 26 Jun 2026 | 33.98 HKD | 8.4% | 41.86 HKD | 37.11 HKD | -1.24 | -12.39 | 2.5M | Off |
| 19 Jun 2026 | 31.34 HKD | -3.5% | 42.05 HKD | 37.17 HKD | -1.34 | -23.40 | 7.9M | Off |
| 12 Jun 2026 | 32.47 HKD | 2.9% | 42.22 HKD | 37.23 HKD | -1.38 | -23.39 | 1.1M | Off |
| 5 Jun 2026 | 31.55 HKD | 2.5% | 42.61 HKD | 37.35 HKD | -1.27 | -26.61 | 2.0M | Off |
| 29 May 2026 | 30.80 HKD | -3.4% | 42.98 HKD | 37.47 HKD | -1.19 | -29.14 | 8.2M | Off |
| 22 May 2026 | 31.89 HKD | -10.5% | 43.50 HKD | 37.64 HKD | -1.02 | -27.96 | 9.1M | Off |
| 15 May 2026 | 35.63 HKD | -6.2% | 43.83 HKD | 37.81 HKD | -0.96 | -20.60 | 15.6M | Off |
| 8 May 2026 | 38.00 HKD | -4.9% | 44.05 HKD | 37.98 HKD | -0.92 | -16.43 | 6.4M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.